Wells J R, Billing R, Herzog P, Feig S A, Gale R P, Terasaki P, Cline M J
Exp Hematol. 1979;7 Suppl 5:164-9.
We have used in vitro immunotherapy before autologous bone marrow transplantation for three patients with acute lymphoblastic leukemia (ALL). Bone marrow was removed during remission, and mononuclear cells were separated by density-step centrifugation on Ficoll-Hypaque. The cells from each patient were treated with a heteroantiserum and complement to eliminate leukemic cells and were cryopreserved. Following chemotherapy and total body irradiation, the treated marrows were thawed and infused. All the patients showed positive evidence of returning marrow function before death. One patient who survived 4 months showed no evidence of leukemia at post mortem, and marrow sections demonstrated active hematopoiesis of all cell lines.
我们对三名急性淋巴细胞白血病(ALL)患者在自体骨髓移植前进行了体外免疫治疗。在缓解期采集骨髓,通过在Ficoll-Hypaque上进行密度梯度离心分离单核细胞。将每位患者的细胞用异种抗血清和补体处理以清除白血病细胞,然后进行冷冻保存。在化疗和全身照射后,将处理过的骨髓解冻并输注。所有患者在死亡前均显示出骨髓功能恢复的阳性证据。一名存活4个月的患者在死后尸检中未发现白血病迹象,骨髓切片显示所有细胞系均有活跃的造血作用。